Literature DB >> 6549090

European erythema migrans disease and related disorders.

K Weber, G Schierz, B Wilske, V Preac-Mursic.   

Abstract

European erythema migrans disease, lymphocytoma, and acrodermatitis chronica are a group of disorders associated with the bite of ixodid ticks. These disorders are now thought to be due to a single, or closely related, ixodid tick spirochetes. European erythema migrans disease closely resembles Lyme disease. Serological evaluation may help to separate spirochetal lymphocytoma from other pseudolymphomas of nonspirochetal origin and from lymphoma. Acrodermatitis chronica atrophicans, so far observed mainly in Europe, is presumably a late manifestation of this group of spirochetal disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549090      PMCID: PMC2590035     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  34 in total

1.  Lymphadenosis benigna cutis (LABC), its nature, course and prognosis.

Authors:  B BAFVERSTEDT
Journal:  Acta Derm Venereol       Date:  1960       Impact factor: 4.437

2.  [Acrodermatitis chronica atrophicans, with special reference to the lymph nodes close to the skin, of the bone marrow, the blood proteins as well as to etiology and pathogenesis].

Authors:  W HAUSER
Journal:  Arch Klin Exp Dermatol       Date:  1955

3.  [Erythema chronicum migrans in the early stage of acrodermatitis chronica atrophicans Herxheimer].

Authors:  E LUDWIG
Journal:  Hautarzt       Date:  1956-01       Impact factor: 0.751

4.  [Acrodermatitis chronica atrophicans Herxheimer; a new indication for chloromycetin].

Authors:  H GOTZ
Journal:  Hautarzt       Date:  1952-07       Impact factor: 0.751

5.  Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer).

Authors:  H C Hopf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-05       Impact factor: 10.154

6.  [Lymphocytoma after tick bite].

Authors:  J M PASCHOUD
Journal:  Dermatologica       Date:  1954 Apr-Jun

7.  The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer).

Authors:  N THYRESSON
Journal:  Acta Derm Venereol       Date:  1949       Impact factor: 4.437

8.  Successful treatment of erythema migrans Afzelius.

Authors:  E HOLLSTROM
Journal:  Acta Derm Venereol       Date:  1951       Impact factor: 4.437

9.  Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

Authors:  A C Steere; S E Malawista; J A Hardin; S Ruddy; W Askenase; W A Andiman
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

10.  [Chronic erythema migrans and tick-transmitted meningopolyneuritis (Garin-Bujadoux-Bannwarth): Borrelia infections?].

Authors:  R Ackermann
Journal:  Dtsch Med Wochenschr       Date:  1983-04-15       Impact factor: 0.628

View more
  17 in total

Review 1.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

2.  Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany.

Authors:  P Herzer; B Wilske; V Preac-Mursic; G Schierz; M Schattenkirchner; N Zöllner
Journal:  Klin Wochenschr       Date:  1986-03-03

3.  Lymphocytic meningoradiculitis of Bannwarth and erythema migrans disease.

Authors:  K Weber
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

4.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

5.  Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR.

Authors:  U Busch; C Hizo-Teufel; R Boehmer; V Fingerle; H Nitschko; B Wilske; V Preac-Mursic
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

6.  Genotypic and phenotypic analysis of Borrelia burgdorferi isolates from The Netherlands.

Authors:  L M Nohlmans; R de Boer; A E van den Bogaard; C P van Boven
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

7.  Characterization of a circular plasmid from Borrelia burgdorferi, etiologic agent of Lyme disease.

Authors:  F W Hyde; R C Johnson
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.

Authors:  G Zumstein; R Fuchs; A Hofmann; V Preac-Mursic; E Soutschek; B Wilske
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 9.  The neuropsychiatric manifestations of Lyme borreliosis.

Authors:  B A Fallon; J A Nields; J J Burrascano; K Liegner; D DelBene; M R Liebowitz
Journal:  Psychiatr Q       Date:  1992

10.  Reinfection in erythema migrans disease.

Authors:  K Weber; G Schierz; B Wilske; U Neubert; H E Krampitz; A G Barbour; W Burgdorfer
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.